These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1872284)

  • 21. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
    Döring G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized double-blind comparison of the effects of isosorbide dinitrate retard, verapamil sustained-release, and their combination on myocardial ischemic episodes.
    Friedensohn A; Meshulam R; Schlesinger Z
    Cardiology; 1991; 79 Suppl 2():31-40. PubMed ID: 1760827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paradoxical electrocardiographic effects of amyl nitrite in coronary artery disease.
    Kerber RE; Harrison DC
    Br Heart J; 1972 Aug; 34(8):851-7. PubMed ID: 5070117
    [No Abstract]   [Full Text] [Related]  

  • 24. Editorial: Antiangina or antimyocaridal ischemia drugs.
    Kattus AA
    Chest; 1975 Jun; 67(6):632-3. PubMed ID: 805036
    [No Abstract]   [Full Text] [Related]  

  • 25. Improvement by isosorbide dinitrate of exercise-induced regional myocardial dysfunction.
    Kumada T; Gallagher KP; Miller M; McKown M; White F; McKown D; Kemper WS; Ross J
    Am J Physiol; 1980 Sep; 239(3):H399-405. PubMed ID: 7435586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of antianginal therapy with a calcium antagonist and nitrates on dobutamine-atropine stress echocardiography. Comparison with exercise electrocardiography.
    Dodi C; Pingitore A; Sicari R; Bruno G; Cordovil A; Picano E
    Eur Heart J; 1997 Feb; 18(2):242-7. PubMed ID: 9043840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ergometric study of the association of a beta-blocker and a nitrate derivative].
    Jullien G
    Nouv Presse Med; 1978 Sep; 7(31):2727-31. PubMed ID: 30951
    [No Abstract]   [Full Text] [Related]  

  • 28. [Nitrosorbide in the treatment of cardiac insufficiency in patients with ischemic heart disease].
    Kupchinskaia EG
    Vrach Delo; 1983 Jan; (1):21-3. PubMed ID: 6868491
    [No Abstract]   [Full Text] [Related]  

  • 29. Characteristics and clinical significance of silent myocardial ischemia during ambulatory electrocardiographic monitoring in patients with ischemic heart disease.
    Kohya T; Tomita F; Yasuda H
    Jpn J Med; 1990; 29(6):671-2. PubMed ID: 1983201
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of ischemic heart disease with beta-receptor blockers and isosorbide dinitrate (author's transl)].
    Wermuth G
    MMW Munch Med Wochenschr; 1975 Oct; 117(40):1613-4. PubMed ID: 241932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Isosorbide-5-mononitrate. Hemodynamic studies during subchronic therapy].
    Wiechmann HW; Schuster P; Trieb G
    Med Welt; 1983 Jul; 34(27):765-7. PubMed ID: 6888248
    [No Abstract]   [Full Text] [Related]  

  • 32. Separate and combined effects of pindolol and isosorbide dinitrate in standardized exercise tests of patients with angina pectoris.
    Zetterquist S; Furberg C; Ringqvist I; Söderholm B
    Curr Ther Res Clin Exp; 1975 Feb; 17(2):139-48. PubMed ID: 803427
    [No Abstract]   [Full Text] [Related]  

  • 33. [Regional myocardial blood flow distribution (RMBF) and the influence of isosorbide dinitrate (ISDN) in patients with and without coronary heart disease (KHE)].
    Dirschinger J; Fleck E; Redl A; Rudolph W
    Verh Dtsch Ges Kreislaufforsch; 1975; 41():180-1. PubMed ID: 1231309
    [No Abstract]   [Full Text] [Related]  

  • 34. [Elantan in coronary heart disease. Report of experiences].
    Jahed M
    ZFA (Stuttgart); 1983 Aug; 59(22):1234-5. PubMed ID: 6624210
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of a combination of pindolol and isosorbide dinitrate on ischemic ST-segment depression and exercise ability in angina pectoris.
    Dorow P; Schiess W
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):419-22. PubMed ID: 6386704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Development of tolerance with regard to the anti-ischemic effect of isosorbide dinitrate in regular multiple daily administration].
    Reiniger G; Blasini R; Brügmann U; Rudolph W
    Herz; 1984 Jun; 9(3):146-52. PubMed ID: 6430768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Short-term and long-term therapy with slow-release ISDN. Echographic, vector cardiographic and ergometric findings (author's transl)].
    Mengden HJ; Just H; Giesecke J
    MMW Munch Med Wochenschr; 1978 Aug; 120(34):1085-90. PubMed ID: 308160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of transesophageal electrical stimulation of the left atrium for assessing the anti-ischemic effect of nitrosorbide].
    Mironova IIu; Liakishev AA; Kozlov SG; Sidorenko BA
    Kardiologiia; 1986 Nov; 26(11):47-51. PubMed ID: 3807127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antianginal efficacy of isosorbide dinitrate: dose-response relation and long-term effects of high-dose treatment.
    Schneider W; Bussmann WD; Stahl B; Wietschoreck A; Kaltenbach M
    Z Kardiol; 1985; 74 Suppl 1():55-63. PubMed ID: 3922143
    [No Abstract]   [Full Text] [Related]  

  • 40. Antianginal efficacy of oral therapy with isosorbide dinitrate capsules. Prolonged benefit shown by exercise testing in patients with ischemic heart disease.
    Lee G; Mason DT; Amsterdam EA; Miller RR; DeMaria AN
    Chest; 1978 Mar; 73(3):327-32. PubMed ID: 344006
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.